Back
ESC Premium Access

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Session: Drug therapy in congenital heart disease - What are the options and the needs?
Topic: Intervention
Speaker: Doctor C. Yan (Beijing, CN)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Chaowu Yan

Fuwai Hospital, CAMS and PUMC, Beijing (China)
0 follower

4 more presentations in this session

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

Speaker: Assistant Professor M. Westhoff-Bleck (Hannover, DE)

Access
Abstract
Slides
Video
Thumbnail

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Speaker: Miss H. Yang (Amsterdam, NL)

Access
Abstract
Thumbnail

Drug therapy in adult congenital heart disease: the burden of polypharmacy

Speaker: Ms O. Woudstra (Amsterdam, NL)

Access
Abstract
Thumbnail

Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation

Speaker: Mr B. Ruijsink (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Drug therapy in congenital heart disease - What are the options and the needs?

Speakers: Doctor C. Yan, Assistant Professor M. Westhoff-Bleck, Miss H. Yang, Ms O. Woudstra, Mr B. Ruijsink
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb